{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:27:20Z","timestamp":1782275240012,"version":"3.54.5"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.bbrc.2025.152823","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T21:39:02Z","timestamp":1761341942000},"page":"152823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["AAV9-mediated NGLY1 gene replacement suppresses non-epileptic convulsions in Ngly1 rats"],"prefix":"10.1016","volume":"790","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5833-7704","authenticated-orcid":false,"given":"Makoto","family":"Asahina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-3406","authenticated-orcid":false,"given":"Reiko","family":"Fujinawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yukitake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1030-7631","authenticated-orcid":false,"given":"Tadashi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2025.152823_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2012-100819","article-title":"Clinical application of exome sequencing in undiagnosed genetic conditions","volume":"49","author":"Need","year":"2012","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbagen.2023.130379","article-title":"NGLY1: a fascinating, multifunctional molecule","volume":"1868","author":"Suzuki","year":"2024","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.bbrc.2025.152823_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1083\/jcb.149.5.1039","article-title":"PNG1, a yeast gene encoding a highly conserved peptide:N-glycanase","volume":"149","author":"Suzuki","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbrc.2025.152823_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2015.11.021","article-title":"The cytoplasmic peptide:N-glycanase (NGLY1) \u2013 structure, expression and cellular functions","volume":"577","author":"Suzuki","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2025.152823_bib5","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/emboj\/cdg107","article-title":"A role for N-glycanase in the cytosolic turnover of glycoproteins","volume":"22","author":"Hirsch","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2025.152823_bib6","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.1414593112","article-title":"Endo-\u03b2-N-acetylglucosaminidase forms N-GlcNAc protein aggregates during ER-associated degradation in Ngly1-defective cells","volume":"112","author":"Huang","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2025.152823_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/jb\/mvu068","article-title":"The cytoplasmic peptide:N-glycanase (Ngly1) \u2013 basic science encounters a human genetic disorder","volume":"157","author":"Suzuki","year":"2015","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2025.152823_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ymgme.2019.07.001","article-title":"Aspartylglycosamine is a biomarker for NGLY1-CDDG, a congenital disorder of deglycosylation","volume":"127","author":"Haijes","year":"2019","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.bbrc.2025.152823_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/jb\/mvab111","article-title":"GlcNAc-Asn is a biomarker for NGLY1 deficiency","volume":"171","author":"Mueller","year":"2022","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2025.152823_bib10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2183\/pjab.97.005","article-title":"JF1\/B6F1 Ngly1\u2013\/\u2013 mouse as an isogenic animal model of NGLY1 deficiency","volume":"97","author":"Asahina","year":"2021","journal-title":"Proc. Jpn. Acad. Ser. B"},{"key":"10.1016\/j.bbrc.2025.152823_bib11","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/hmg\/ddad106","article-title":"NGLY1 deficiency: a prospective natural history study","volume":"32","author":"Tong","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib12","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/gim.2014.22","article-title":"Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway","volume":"16","author":"Enns","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2025.152823_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ajmg.a.36889","article-title":"Multi-systemic involvement in NGLY1-related disorder caused by two novel mutations","volume":"A 167A","author":"Heeley","year":"2015","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejmg.2014.08.008","article-title":"NGLY1 mutation causes neuromotor impairment, intellectual disability, and neuropathy","volume":"58","author":"Caglayan","year":"2015","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib15","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/gim.2016.75","article-title":"Prospective phenotyping of NGLY1-CDDG, the first congenital disorder of deglycosylation","volume":"19","author":"Lam","year":"2017","journal-title":"Genet. Med."},{"key":"10.1016\/j.bbrc.2025.152823_bib16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/ejhg.2015.186","article-title":"Novel genetic causes for cerebral visual impairment","volume":"24","author":"Bosch","year":"2016","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s10038-019-0719-9","article-title":"Novel NGLY1 gene variants in Chinese children with global developmental delay, microcephaly, hypotonia, hypertransaminasemia, alacrimia, and feeding difficulty","volume":"65","author":"Abuduxikuer","year":"2020","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12881-020-01067-1","article-title":"Two novel compound heterozygous mutations in NGLY1 as a cause of congenital disorder of deglycosylation: a case presentation","volume":"21","author":"Ge","year":"2020","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib19","first-page":"148","article-title":"Orthopaedic phenotyping of NGLY1 deficiency using an international, family-led disease registry, Orphanet J","volume":"14","author":"Cahan","year":"2019","journal-title":"Rare Dis."},{"key":"10.1016\/j.bbrc.2025.152823_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5114\/pjp.2020.92994","article-title":"Liver involvement in NGLY1 congenital disorder of deglycosylation","volume":"71","author":"Lipi\u0144ski","year":"2020","journal-title":"Pol. J. Pathol."},{"key":"10.1016\/j.bbrc.2025.152823_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2020.103952","article-title":"Acute liver failure in a male patient with NGLY1-congenital disorder of deglycosylation","volume":"63","author":"Rios-Flores","year":"2020","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2021.104146","article-title":"NGLY1 deficiency: novel variants and literature review","volume":"64","author":"Kariminejad","year":"2021","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3390\/life11030187","article-title":"NGLY1 deficiency: a rare newly described condition with a typical presentation","volume":"11","author":"Dabaj","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.bbrc.2025.152823_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s13023-022-02592-3","article-title":"NGLY1 deficiency: estimated incidence, clinical features, and genotypic spectrum from the NGLY1 Registry","volume":"17","author":"Stanclift","year":"2022","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bbrc.2025.152823_bib25","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/jimd.12494","article-title":"Delineating the epilepsy phenotype of NGLY1 deficiency","volume":"45","author":"Levy","year":"2022","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2025.152823_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2022.104558","article-title":"Expanding the NGLY1 deficiency phenotype: case report of an atypical patient","volume":"65","author":"Nolan","year":"2022","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2023.104895","article-title":"Progressive myoclonic epilepsy as an expanding phenotype of NGLY1-associated congenital deglycosylation disorder: a case report and review of the literature","volume":"67","author":"Sonoda","year":"2024","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib28","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/hmg\/ddaa059","article-title":"Ngly1\u2013\/\u2013 rats develop neurodegenerative phenotypes and pathological abnormalities in their peripheral and central nervous systems","volume":"29","author":"Asahina","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s11689-018-9234-0","article-title":"Recent progress and considerations for AAV gene therapies targeting the central nervous system","volume":"10","author":"Lykken","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.bbrc.2025.152823_bib30","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/s41573-023-00766-7","article-title":"AAV-based in vivo gene therapy for neurological disorders","volume":"22","author":"Ling","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2025.152823_bib31","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-dose gene-replacement therapy for spinal muscular atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2025.152823_bib32","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13041-021-00806-6","article-title":"Reversibility of motor dysfunction in the rat model of NGLY1 deficiency","volume":"14","author":"Asahina","year":"2021","journal-title":"Mol. Brain"},{"key":"10.1016\/j.bbrc.2025.152823_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.omtm.2022.09.015","article-title":"AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 deficiency","volume":"27","author":"Zhu","year":"2022","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bbrc.2025.152823_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101524","article-title":"Preclinical pharmacology and safety studies to support an AAV9 NGLY1 gene therapy clinical trial for the treatment of NGLY1 deficiency","volume":"33","author":"Zhu","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.bbrc.2025.152823_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.183189","article-title":"Systemic gene therapy corrects the neurological phenotype in a mouse model of NGLY1 deficiency","volume":"9","author":"Du","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2025.152823_bib36","series-title":"The Rat Brain in Stereotaxic Coordinates","first-page":"123","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.bbrc.2025.152823_bib37","series-title":"Glycoscience Protocols (Glycopodv2) [Internet], Japan Consortium for Glycobiology and Glycotechnology, Saitama","article-title":"Enzyme assay of endogenous activity of peptide-N-glycanase (PNGase)\/N-glycanase 1 (NGLY1) in cells and tissues using glycosylated cyclopeptide as a substrate","author":"Hirayama","year":"2021"},{"key":"10.1016\/j.bbrc.2025.152823_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/glycob\/cwab115","article-title":"A method for assaying peptide:N-glycanase\/N-glycanase 1 activities in crude extracts using an N-glycosylated cyclopeptide","volume":"32","author":"Hirayama","year":"2022","journal-title":"Glycobiology"},{"key":"10.1016\/j.bbrc.2025.152823_bib39","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s42003-024-06131-7","article-title":"Intranasal oxytocin suppresses seizure-like behaviors in a mouse model of NGLY1 deficiency","volume":"7","author":"Makita","year":"2024","journal-title":"Commun. Biol."},{"key":"10.1016\/j.bbrc.2025.152823_bib40","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nrn1787","article-title":"Critical period plasticity in local cortical circuits","volume":"6","author":"Hensch","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbrc.2025.152823_bib41","first-page":"R1612","article-title":"Maturation of sleep homeostasis in developing rats: a role for sleep-promoting systems","volume":"298","author":"Shaffner","year":"2010","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.bbrc.2025.152823_bib42","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nbt.1610","article-title":"Rescue of the spinal muscular atrophy phenotype in a mouse model by postnatal intravenous administration of AAV9-SMN","volume":"28","author":"Foust","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bbrc.2025.152823_bib43","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41591-022-01866-4","article-title":"Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial","volume":"28","author":"Strauss","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2025.152823_bib44","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1089\/hgtb.2013.076","article-title":"Transduction of the central nervous system after intracerebroventricular injection of adeno-associated viral vectors in neonatal and juvenile mice","volume":"24","author":"Chakrabarty","year":"2013","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.bbrc.2025.152823_bib45","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0896-6273(03)00065-5","article-title":"Neuronal plasticity in thalamocortical networks during sleep and waking oscillations","volume":"37","author":"Steriade","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.bbrc.2025.152823_bib46","first-page":"1302.4051","article-title":"On-off intermittency of thalamo-cortical oscillations in the electroencephalogram of rats with genetic predisposition to absence epilepsy","author":"Sitnikova","year":"2013","journal-title":"arXiv"},{"key":"10.1016\/j.bbrc.2025.152823_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006696","article-title":"Lethality of mice bearing a knockout of the Ngly1-gene is partially rescued by the additional deletion of the Engase gene","volume":"13","author":"Fujihira","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.bbrc.2025.152823_bib49","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2102902118","article-title":"Loss of peptide:N-glycanase causes proteasome dysfunction mediated by a sugar-recognizing ubiquitin ligase","volume":"118","author":"Yoshida","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.bbrc.2025.152823_bib50","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/j.molcel.2024.07.013","article-title":"Sugar-mediated non-canonical ubiquitination impairs Nrf1\/NFE2L1 activation","volume":"84","author":"Yoshida","year":"2024","journal-title":"Mol. Cells"},{"key":"10.1016\/j.bbrc.2025.152823_bib51","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20242296","article-title":"The STING pathway drives noninflammatory neurodegeneration in NGLY1 deficiency","volume":"222","author":"Yang","year":"2025","journal-title":"J. Exp. Med."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25015396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X25015396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:47:48Z","timestamp":1763700468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X25015396"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"alternative-id":["S0006291X25015396"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152823","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV9-mediated NGLY1 gene replacement suppresses non-epileptic convulsions in Ngly1\u2212\/\u2212 rats","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2025.152823","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152823"}}